Verde Bio EBITDA margin
Quel est le EBITDA margin de Verde Bio?
Le EBITDA margin de Verde Bio Holdings, Inc. est -342.66%
Quelle est la définition de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin des entreprises dans Finance secteur sur OTC par rapport à Verde Bio
Que fait Verde Bio?
Verde Bio Holdings, Inc. engages in the oil and gas exploration and investment business. It has mineral and royalty interests in various properties. The company was formerly known as Appiphany Technologies Holdings Corp. and changed its name to Verde Bio Holdings, Inc. in May 2020. Verde Bio Holdings, Inc. was incorporated in 2010 and is based in Frisco, Texas.
Entreprises avec ebitda margin similaire à Verde Bio
- Exicure a EBITDA margin de -343.51%
- Exicure a EBITDA margin de -343.51%
- AdAlta a EBITDA margin de -343.26%
- Golden Valley Mines a EBITDA margin de -343.06%
- Golden Valley Mines a EBITDA margin de -343.06%
- Endexx a EBITDA margin de -342.80%
- Verde Bio a EBITDA margin de -342.66%
- Keyne Ltd a EBITDA margin de -342.52%
- Newfield Resources a EBITDA margin de -342.47%
- Genomic Vision Societe Anonyme a EBITDA margin de -342.13%
- Génomic Vision SA a EBITDA margin de -342.13%
- Remark Inc a EBITDA margin de -341.55%
- Versus Systems a EBITDA margin de -341.28%